Statins in multiple sclerosis: a new therapeutic option?

Hemmer B , Archelos JJ , Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis . Nat Rev Neurosci 2002; 3: 291-301 .

Neuhaus O , Archelos JJ , Hartung HP. Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection . Trends Pharmacol Sci 2003; 24: 131-138 .

Cutts JL , Scallen TJ , Watson J , Bankhurst AD. Role of mevalonic acid in the regulation of natural killer cell cytotoxicity . J Cell Physiol 1989; 139: 550-557 .

Kurakata S , Kada M , Shimada Y , Komai T , Nomoto K. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro . Immunopharmacology 1996; 34: 51-61 .

Stanislaus R , Singh AK , Singh I. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis . J Neurosci Res 2001; 66: 155-162 .

Youssef S , Stuve O , Patarroyo JC , Ruiz PJ , Radosevich JL , Hur EM et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease . Nature 2002; 420: 78-84 .

Aktas O , Waiczies S , Smorodchenko A , Dorr J , Seeger B , Prozorovski T et al. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin . J Exp Med 2003; 197: 725-733 .

Greenwood J , Walters CE , Pryce G , Kanunga N , Beraud E , Baker D et al. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis . FASEB J 2003; 10.1096/fj.021014fje.

Neuhaus O , Strasser-Fuchs S , Fazekas F , Kieseier BC , Niederwieser G , Hartung HP et al. Statins as immunomodulators: comparison with interferon-beta1b in MS . Neurology 2002; 59: 990-997 .

Vollmer T , Durkalski V , Tyor W , Corboy J , Preiningerova J , Markovic-Plese S et al. An open-label, single arm study of simvastatin as a therapy for multiple sclerosis (MS) . Neurology 2003; 60(Suppl 1): A84-A84 (abstract).

Baker D , Adamson P , Greenwood J. Potential of statins for the treatment of multiple sclerosis . Lancet Neurol 2003; 2: 9-10 .

Takemoto M , Liao JK. Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors . Arterioscler Thromb Vasc Biol 2001; 21: 1712-1719 .

Weitz-Schmidt G. Statins as anti-inflammatory agents . Trends Pharmacol Sci 2002; 23: 482-486 .

Singh R , Wang B , Shirvaikar A , Khan S , Kamat S , Schelling JR et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation . J Clin Invest 1999; 103: 1561-1570 .

Weitz-Schmidt G , Welzenbach K , Brinkmann V , Kamata T , Kallen J , Bruns C et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site . Nat Med 2001; 7: 687-692 .

Archelos JJ , Hartung HP. The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications . Mol Med Today 1997; 3: 310-321 .

Kwak B , Mulhaupt F , Myit S , Mach F. Statins as a newly recognized type of immunomodulator . Nat Med 2000; 6: 1399-1402 .

Wekerle H. Tackling multiple sclerosis . Nature 2002; 420: 39-40 .